EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   1.1.1.357 | Adenocarcinoma |
17909007 |
A novel variant of ileal bile acid binding protein is up-regulated through nuclear factor-kappaB activation in colorectal adenocarcinoma. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
| 1.1.1.357 | Adenocarcinoma |
22670171 |
Aldo-keto reductase family 1 member C3 (AKR1C3) is expressed in adenocarcinoma and squamous cell carcinoma but not small cell carcinoma. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
3
3
1
0 |
| 1.1.1.357 | Adenocarcinoma |
24228104 |
Expression of aldo-keto reductase family 1 member C3 (AKR1C3) in neuroendocrine tumors & adenocarcinomas of pancreas, gastrointestinal tract, and lung. |
causal interaction
diagnostic usage
ongoing research
unassigned |
2
2
4
0 |
| 1.1.1.357 | Alzheimer Disease |
31593867 |
Increased ileal bile acid binding protein and galectin-9 are associated with mild cognitive impairment and Alzheimer's disease. |
causal interaction
unassigned |
4
0 |
| 1.1.1.357 | Carcinoma |
22670171 |
Aldo-keto reductase family 1 member C3 (AKR1C3) is expressed in adenocarcinoma and squamous cell carcinoma but not small cell carcinoma. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
3
3
1
0 |
| 1.1.1.357 | Carcinoma, Small Cell |
22670171 |
Aldo-keto reductase family 1 member C3 (AKR1C3) is expressed in adenocarcinoma and squamous cell carcinoma but not small cell carcinoma. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
3
3
1
0 |
| 1.1.1.357 | Carcinoma, Squamous Cell |
22670171 |
Aldo-keto reductase family 1 member C3 (AKR1C3) is expressed in adenocarcinoma and squamous cell carcinoma but not small cell carcinoma. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
3
3
1
0 |
| 1.1.1.357 | Cholestasis |
28239322 |
Intestinal barrier integrity and function in infants with cholestasis. |
diagnostic usage
ongoing research
unassigned |
4
3
0 |
| 1.1.1.357 | Choriocarcinoma |
25170291 |
AKR1C3 overexpression mediates methotrexate resistance in choriocarcinoma cells. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
3
4
4 |
| 1.1.1.357 | Colitis, Ulcerative |
32003543 |
Microproteomics and Immunohistochemistry Reveal Differences in Aldo-Keto Reductase Family 1 Member C3 in Tissue Specimens of Ulcerative Colitis and Crohn's Disease. |
ongoing research
unassigned |
2
0 |
